Last Action | 02/19/25: to Committee on Committees (H) |
---|---|
Title | AN ACT relating to buprenorphine products. |
Bill Documents | Introduced |
Bill Request Number | 951 |
Sponsor | K. Moser |
Summary of Original Version | Create a new section of KRS Chapter 311 to require that a dosage regimen for Buprenorphine-Mono-Product or Buprenorphine-Combined-with-Naloxone prescribed by a licensed physician to meet the treatment needs of a patient; require the Kentucky Board of Medical Licensure to promulgate administrative regulations to implement the requirement; create a new section of KRS Chapter 314 to require that a dosage regimen for Buprenorphine-Mono-Product or Buprenorphine-Combined-with-Naloxone prescribed by a licensed advanced practice registered nurse meet the treatment needs of a patient; require the Kentucky Board of Nursing to promulgate administrative regulations to implement the requirement. |
Index Headings of Original Version |
Drugs and Medicines - Buprenorphine products, dosage regimen Health and Medical Services - Buprenorphine products, dosage regimen Nurses - Buprenorphine products, dosage regimen Physicians and Practitioners - Buprenorphine products, dosage regimen Substance Abuse - Buprenorphine products, dosage regimen Administrative Regulations and Proceedings - Board of Medical Licensure, buprenorphine products, dosage regimen Administrative Regulations and Proceedings - Board of Nursing, buprenorphine products, dosage regimen Boards and Commissions - Board of Medical Licensure, buprenorphine products, dosage regimen Boards and Commissions - Board of Nursing, buprenorphine products, dosage regimen |
02/19/25 |
|
---|
Last updated: 2/21/2025 4:29 PM (EST)